Study Evaluating Efficacy And Tolerability Of Veliparib in Combination With Temozolomide (TMZ) or In Combination With Carboplatin and Paclitaxel Versus Placebo in Participants With Breast Cancer Gene (BRCA)1 and BRCA2 Mutation and Metastatic Breast Cancer
Clinical trial NCT01506609 · COMPLETED
Trial details
- NCT number
- NCT01506609
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-23
- Primary completion
- 2018-12-13
- Enrollment
- 294
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.